Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsBUCCALGeneric

ORETON

METHYLTESTOSTERONE

Standard Dose
10MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview ORETON is listed in Drugs@FDA under application 080281 (ANDA).

Marketing status: Discontinued Active ingredient METHYLTESTOSTERONE Form and strength TABLET;BUCCAL - 10MG Sponsor SCHERING Submission history Latest submission status date: 1994-01-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview ORETON is listed in Drugs@FDA under application 080281 (ANDA). Marketing status: Discontinued Active ingredient METHYLTESTOSTERONE Form and strength TABLET;BUCCAL - 10MG Sponsor SCHERING Submission history Latest submission status date: 1994-01-19 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
ORETON (METHYLTESTOSTERONE) | Drug Monograph | MedicHelpline